Vertex Pharmaceuticals
vrtx.comLocations
United States · Cambridge, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA
founded in
1989
KALYDECO is a prescription medicine used for the treatment of Cystic Fibrosis (CF) in patients age 6 years and older who have one of the following mutations in their CF gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R. KALYDECO is not for use in people with CF due to other mutations in the CF gene. KALYDECO is not effective in patients with CF with two copies of the F508del mutation (F508del/F508del) in the CF gene. It is not known if KALYDECO is safe and effective in children under 6 years of age.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the MassCyberCenter network.
Something looks off?
Open jobs at Vertex Pharmaceuticals
On-site & Remote
Seniority
Salary